The present invention relates to an anti-tumoral compound for the localized treatment of neoplastic pathologies of malignant kind that cannot be surgically removed or with a high risk of local recurrence, comprising: a bicomponent injectable biologic glue； an antineoplastic substance； an epinephrine-based solution. Said compound may be used as an independent therapeutic treatment, as it allows to treat tumoral masses that are not surgically removable, or as a therapeutic treatment complementary to surgical removal or to known ablative techniques (laser, radiofrequency, microwaves, etc.) for a maximization of the efficiency of said therapies reducing the risk of neoplastic relapses in the original surgical site. A process for the production of said antitumor compound is also object of the present invention.
